Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00592605 · ClinicalTrials.gov registry record
Thyroid Disease Serum Repository
A clinical trial of Thyroid Disease, sponsored by University of Arkansas.
- Completed
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT00592605 is a study of Thyroid Disease that has completed, run by University of Arkansas. The registered enrollment target is 1,000 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00592605, a study of Thyroid Disease, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Thyroid disease is more common among females and is increasing in incidence. Otolaryngology faculty members and residents will perform head and neck examinations as part of the subject's routine care. If the participant is noted to have thyroid disease, they will be asked if they would like to participate in the research portion by having approximately 10cc's of blood drawn. Faculty and staff will complete a data collection sheet that will contain demographic and clinical data.
Conditions Studied
Study Locations (1)
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2007-05 |
| Est. Completion | 2017-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00592605
The ClinicalTrials.gov registry entry for NCT00592605 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Thyroid Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00592605 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.
Frequently Asked Questions
What is clinical trial NCT00592605 about?
NCT00592605 is a clinical study titled "Thyroid Disease Serum Repository". Thyroid disease is more common among females and is increasing in incidence. Otolaryngology faculty members and residents will perform head and neck examinations as part of the subject's routine care. If the participant is noted to have thyroid disease, they will be asked if they would like to part...
What is the current status of trial NCT00592605?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2007-05. Estimated completion is 2017-06-01.
What conditions does trial NCT00592605 study?
This clinical trial studies the following conditions: Thyroid Disease.
Who is sponsoring clinical trial NCT00592605?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00592605 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thyroid Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.